PLAQUENIL Side Effects

7016742-8 | Chromaturia, Faeces Discoloured, Hepatotoxicity, Ocular Icterus
on Sep 10, 2010 Male patient from UNITED STATES , 84 years of age, was diagnosed with polymyalgia rheumatica (What is polymyalgia rheumatica?) and was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: chromaturia, faeces discoloured, hepatotoxicity, ocular icterus. Plaquenil dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), OPHTHALMOLOGICALS (View Ophthalmologicals Review and Ophthalmologicals Label ). Patient was hospitalized.

7015040-6 | Deafness, Tinnitus
Patient was taking Plaquenil (View Usage). Patient had the following side effects: deafness, tinnitus (What is tinnitus?) on Sep 16, 2010 from DENMARK Additional patient health information: Female patient , 54 years of age, was diagnosed with seronegative arthritis, gallbladder disorder, hypercholesterolaemia and. Plaquenil dosage: . During the same period patient was treated with BUSCOPAN (View Buscopan Review and Buscopan Label ), TODOLAC (View Todolac Review and Todolac Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

7007338-2 | Dermatitis Exfoliative, Product Quality Issue
Adverse event was reported on Sep 08, 2010 by a Female patient taking Plaquenil (View Usage) (Dosage: ) was diagnosed with arthritis (What is arthritis?) and. Location: UNITED KINGDOM , 62 years of age, weighting 185.2 lb, After Plaquenil was administered, patient had the following side effects: dermatitis exfoliative, product quality issue.

6968638-5 | Arthralgia, Condition Aggravated, Cutaneous Lupus Erythematosus, Rash Maculo-papular
on Sep 03, 2010 Female patient from FRANCE , weighting 121.3 lb, was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, condition aggravated, cutaneous lupus erythematosus, rash maculo-papular. Plaquenil dosage: . Patient was hospitalized.


6945161-5 | Arthralgia, Joint Stiffness, Lymphoedema, Oedema Peripheral, Psoriasis, Tendonitis
on Aug 18, 2010 Female patient from FRANCE , 62 years of age, weighting 180.8 lb, was treated with Plaquenil (View Usage). Patient had the following side effects: arthralgia, joint stiffness, lymphoedema, oedema peripheral, psoriasis, tendonitis. Plaquenil dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PREVISCAN (View Previscan Review and Previscan Label ), KARDEGIC (View Kardegic Review and Kardegic Label ).

6879927-7 | Muscle Twitching, Muscular Weakness
Patient was taking Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: muscle twitching, muscular weakness on Jul 27, 2010 from AUSTRALIA Additional patient health information: Male patient , 70 years of age, weighting 164.2 lb, . Plaquenil dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATACAND HCT (View Atacand Hct Review and Atacand Hct Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6859970-4 | Disorientation, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram Qt Prolonged, Hypokalaemia, Hypotension, Metabolic Acidosis, Overdose
Adverse event was reported on Jul 08, 2010 by a Female patient taking Plaquenil (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: CANADA , 23 years of age, Patient experienced the following unwanted or unexpected effects: disorientation, electrocardiogram qrs complex prolonged, electrocardiogram qt prolonged, hypokalaemia, hypotension, metabolic acidosis, overdose. Patient was hospitalized.

6847971-1 | Disorientation, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram Qt Prolonged, Hypokalaemia, Hypotension, Metabolic Acidosis, Overdose
on Jul 05, 2010 Female patient from CANADA , 23 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). Patient had the following side effects: disorientation, electrocardiogram qrs complex prolonged, electrocardiogram qt prolonged, hypokalaemia, hypotension, metabolic acidosis, overdose. Plaquenil dosage: . Patient was hospitalized.

6831875-4 | Aplasia Pure Red Cell
on Dec 28, 2009 Female patient from FRANCE , 70 years of age, was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: aplasia pure red cell. Plaquenil dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), TAHOR (View Tahor Review and Tahor Label ), LAMALINE (View Lamaline Review and Lamaline Label ), MOTILIUM (View Motilium Review and Motilium Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SEROPLEX (View Seroplex Review and Seroplex Label ). Patient was hospitalized.

6809362-9 | Hypoglycaemia, Loss Of Consciousness
Patient was taking Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, loss of consciousness on Jun 22, 2010 from MALAYSIA Additional patient health information: Female patient , 80 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Plaquenil dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ).

6802880-9 | Supraventricular Tachycardia
Adverse event was reported on Jun 18, 2010 by a Female patient taking Plaquenil (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), arrhythmia (What is arrhythmia?) and. Location: GREECE , 53 years of age, Patient had the following side effects: supraventricular tachycardia. During the same period patient was treated with PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ), CORTIZONE (View Cortizone Review and Cortizone Label ). Patient was hospitalized.

6782644-5 | Squamous Cell Carcinoma Of The Cervix
on Jun 09, 2010 Female patient from FRANCE , 63 years of age, was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: squamous cell carcinoma of the cervix. Plaquenil dosage: . During the same period patient was treated with DISULONE (View Disulone Review and Disulone Label ), MEDROL (View Medrol Review and Medrol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), PROTOPIC (View Protopic Review and Protopic Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), REMICADE (View Remicade Review and Remicade Label ), IMUREL (View Imurel Review and Imurel Label ). Patient was hospitalized.

6779106-8 | Joint Stiffness
on Jun 09, 2010 Female patient from FRANCE , 62 years of age, was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: joint stiffness. Plaquenil dosage: . During the same period patient was treated with CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PREVISCAN (View Previscan Review and Previscan Label ).

6779100-7 | Electrocardiogram Qt Prolonged
Patient was taking Plaquenil (View Usage). Patient had the following side effects: electrocardiogram qt prolonged on Jun 09, 2010 from FRANCE Additional patient health information: Female patient , 50 years of age, . Plaquenil dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized.

6741363-1 | Cyanosis, Dyspnoea, Methaemoglobinaemia
Adverse event was reported on May 18, 2010 by a Female patient taking Plaquenil (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: FRANCE , 24 years of age, After Plaquenil was administered, patient had the following side effects: cyanosis, dyspnoea, methaemoglobinaemia. During the same period patient was treated with DISULONE (View Disulone Review and Disulone Label ).

6727398-3 | Progressive Multifocal Leukoencephalopathy, Retinopathy
on May 05, 2010 Male patient from UNITED STATES , 78 years of age, weighting 218.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy, retinopathy. Plaquenil dosage: . During the same period patient was treated with REMICADE (Every 8 Weeks) (View Remicade Review and Remicade Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (7.5 To 10 Mg) (View Prednisone Review and Prednisone Label ).

6683003-6 | Vulvovaginal Pruritus
on Apr 07, 2010 Female patient from FRANCE , 33 years of age, was treated with Plaquenil (View Usage). Patient had the following side effects: vulvovaginal pruritus. Plaquenil dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6653241-7 | Delusion, Diarrhoea, Electrocardiogram Abnormal, Hair Colour Changes, Hallucination, Hypertrichosis, Hypoaesthesia, Muscular Weakness, Vomiting
Patient was taking Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: delusion, diarrhoea, electrocardiogram abnormal, hair colour changes, hallucination, hypertrichosis, hypoaesthesia, muscular weakness, vomiting on Mar 17, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 80 years of age, . Plaquenil dosage: . During the same period patient was treated with LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ).

6643327-5 | Condition Aggravated, Systemic Lupus Erythematosus
Adverse event was reported on Mar 08, 2010 by a Female patient taking Plaquenil (View Usage) (Dosage: ) . Location: FRANCE , 31 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, systemic lupus erythematosus. During the same period patient was treated with ELISOR (View Elisor Review and Elisor Label ), ACUPAN (View Acupan Review and Acupan Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), DESOGESTREL AND ETHINYL ESTRADIOL (View Desogestrel And Ethinyl Estradiol Review and Desogestrel And Ethinyl Estradiol Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6608017-3 | Chest Pain, Dyspnoea
on Feb 16, 2010 Female patient from CANADA , 28 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea. Plaquenil dosage: . During the same period patient was treated with LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ).

6601363-9 | Angina Pectoris, Dyspnoea
on Feb 16, 2010 Female patient from CANADA , 28 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: angina pectoris, dyspnoea. Plaquenil dosage: . During the same period patient was treated with LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ).

6591033-8 | Electrocardiogram Qt Prolonged
Patient was taking Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged on Feb 10, 2010 from NETHERLANDS Additional patient health information: Female patient , 69 years of age, weighting 105.8 lb, . Plaquenil dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PLAVIX (View Plavix Review and Plavix Label ), EMCOR (View Emcor Review and Emcor Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ACETYLSALICYLZUUR (View Acetylsalicylzuur Review and Acetylsalicylzuur Label ), CRESTOR (View Crestor Review and Crestor Label ), DIHYDRAL (View Dihydral Review and Dihydral Label ). Patient was hospitalized.

6573200-2 | Malnutrition, Weight Decreased
Adverse event was reported on Jan 29, 2010 by a Female patient taking Plaquenil (View Usage) (Dosage: ) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?), epilepsy (What is epilepsy?) and. Location: FRANCE , 33 years of age, Patient had the following side effects: malnutrition, weight decreased. During the same period patient was treated with EPITOMAX (View Epitomax Review and Epitomax Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), NOCERTONE (View Nocertone Review and Nocertone Label ).

6569765-7 | Condition Aggravated, Electrocardiogram Qt Prolonged
on Jan 27, 2010 Female patient from NETHERLANDS , 71 years of age, weighting 156.5 lb, was diagnosed with systemic lupus erythematosus, hypertension and was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: condition aggravated, electrocardiogram qt prolonged. Plaquenil dosage: . During the same period patient was treated with EMCOR (View Emcor Review and Emcor Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), THYRAX (View Thyrax Review and Thyrax Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ). Patient was hospitalized.

6554061-4 | Scotoma
on Jan 25, 2010 Female patient from UNITED STATES , 67 years of age, weighting 140.2 lb, was diagnosed with immune system disorder and was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: scotoma. Plaquenil dosage: 200 Mg Bid Oral.

6553809-2 | Dyspraxia, Jc Virus Infection, Progressive Multifocal Leukoencephalopathy
Patient was taking Plaquenil (View Usage). Patient had the following side effects: dyspraxia, jc virus infection, progressive multifocal leukoencephalopathy on Jan 15, 2010 from FRANCE Additional patient health information: Female patient , 66 years of age, weighting 103.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), antisynthetase syndrome and. Plaquenil dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), IMUREL (View Imurel Review and Imurel Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6535478-0 | Electrocardiogram Qt Prolonged
Adverse event was reported on Jan 05, 2010 by a Female patient taking Plaquenil (View Usage) (Dosage: ) . Location: NETHERLANDS , 69 years of age, weighting 105.8 lb, After Plaquenil was administered, patient had the following side effects: electrocardiogram qt prolonged. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PLAVIX (View Plavix Review and Plavix Label ), EMCOR (View Emcor Review and Emcor Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ACETYLSALICYLZUUR (View Acetylsalicylzuur Review and Acetylsalicylzuur Label ), CRESTOR (View Crestor Review and Crestor Label ), DIHYDRAL (View Dihydral Review and Dihydral Label ). Patient was hospitalized.

6525430-3 | Cardio-respiratory Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
on Dec 24, 2009 Female patient from FRANCE , 84 years of age, was diagnosed with pyoderma gangrenosum and was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, electrocardiogram qt prolonged, torsade de pointes. Plaquenil dosage: . During the same period patient was treated with LAMPRENE (View Lamprene Review and Lamprene Label ), FURADANTIN (View Furadantin Review and Furadantin Label ), TARDYFERON /GFR/ (View Tardyferon /gfr/ Review and Tardyferon /gfr/ Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

6492606-3 | Rash Erythematous
on Dec 11, 2009 Female patient from UNITED STATES , 76 years of age, weighting 140.0 lb, was diagnosed with connective tissue disorder (What is connective tissue disorder?) and was treated with Plaquenil (View Usage). Patient had the following side effects: rash erythematous. Plaquenil dosage: 200 Mg Twice Daily.

6479975-5 | Diarrhoea, Pyrexia
Patient was taking Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: diarrhoea, pyrexia on Nov 27, 2009 from FRANCE Additional patient health information: Female patient , 69 years of age, was diagnosed with sarcoidosis and. Plaquenil dosage: . During the same period patient was treated with METHOTREXATE BELLON (View Methotrexate Bellon Review and Methotrexate Bellon Label ). Patient was hospitalized.

6404735-0 | Dacryostenosis Congenital, Heart Rate Increased, Naevus Flammeus, Premature Baby
Adverse event was reported on Oct 06, 2009 by a Male patient taking Plaquenil (View Usage) (Dosage: ) was diagnosed with cutaneous lupus erythematosus, hypertension and. Location: FRANCE , weighting 6.28 lb, Patient experienced the following unwanted or unexpected effects: dacryostenosis congenital, heart rate increased, naevus flammeus, premature baby. During the same period patient was treated with TARDYFERON B9 (View Tardyferon B9 Review and Tardyferon B9 Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), TRANDATE (View Trandate Review and Trandate Label ), TEMERIT (View Temerit Review and Temerit Label ).

6398999-X | Neonatal Respiratory Distress Syndrome
on Oct 01, 2009 Male patient from SWITZERLAND , weighting 6.81 lb, was diagnosed with systemic lupus erythematosus and was treated with Plaquenil (View Usage). Patient had the following side effects: neonatal respiratory distress syndrome. Plaquenil dosage: .

6382237-8 | Asthenia, Fatigue, Feeling Abnormal, Irritability, Muscle Spasms, Nervousness, Pain, Somnolence, Vision Blurred
on Sep 28, 2009 Female patient from UNITED STATES , weighting 178.0 lb, was diagnosed with bursitis (What is bursitis?), rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: asthenia, fatigue, feeling abnormal, irritability, muscle spasms, nervousness, pain (What is pain?), somnolence, vision blurred. Plaquenil dosage: 2 Daily.

6367514-9 | Amnesia, Atrial Fibrillation, Personality Change
Patient was taking Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, atrial fibrillation (What is atrial fibrillation?), personality change on Sep 10, 2009 from SWEDEN Additional patient health information: Male patient , 56 years of age, was diagnosed with systemic lupus erythematosus and. Plaquenil dosage: . Patient was hospitalized.

6341659-1 | Retinopathy
Adverse event was reported on Sep 02, 2009 by a Female patient taking Plaquenil (View Usage) (Dosage: 200 Mg 12 Pills Week 2 Day 6 Days Week) was diagnosed with systemic lupus erythematosus and. Location: UNITED STATES , weighting 130.0 lb, Patient had the following side effects: retinopathy.

6311747-4 | Anger, Confusional State, Emotional Distress, Eye Disorder, Feeling Abnormal, Memory Impairment, Vision Blurred
on Aug 13, 2009 Female patient from UNITED STATES , weighting 112.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: anger, confusional state, emotional distress, eye disorder, feeling abnormal, memory impairment, vision blurred. Plaquenil dosage: 200 Mg - (2 Tabs) 1 A Day May 20, 2008 - Most Of July 09 Except For Focus.

6306984-9 | Blister, Rash, Vasculitis
on Aug 04, 2009 Female patient from FRANCE , 54 years of age, was diagnosed with systemic lupus erythematosus and was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: blister, rash (What is rash?), vasculitis (What is vasculitis?). Plaquenil dosage: .

6300948-7 | Visual Impairment
Patient was taking Plaquenil (View Usage). Patient had the following side effects: visual impairment on Aug 06, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 100.0 lb, was diagnosed with systemic lupus erythematosus and. Plaquenil dosage: 200mg Twice A Day Oral.

6291543-7 | Condition Aggravated, Product Substitution Issue, Sjogren's Syndrome
Adverse event was reported on Jul 30, 2009 by a Female patient taking Plaquenil (View Usage) (Dosage: 200 Mg Twice Daily Po) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?), systemic lupus erythematosus and. Location: UNITED STATES , 45 years of age, weighting 140.0 lb, After Plaquenil was administered, patient had the following side effects: condition aggravated, product substitution issue, sjogren's syndrome (What is sjogren's syndrome?).

6282895-2 | Lichen Planus, Pruritus
on Jul 22, 2009 Female patient from UNITED STATES , 47 years of age, weighting 185.0 lb, was diagnosed with cutaneous lupus erythematosus, systemic lupus erythematosus and was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: lichen planus, pruritus. Plaquenil dosage: Can't Remember/ 3 Years Ago Daily.

6190088-2 | Alopecia, Blister, Hypersensitivity, Rash Pruritic
on May 13, 2009 Female patient from UNITED STATES , 59 years of age, weighting 170.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). Patient had the following side effects: alopecia, blister, hypersensitivity, rash pruritic. Plaquenil dosage: 200mg 2xdaily Oral.

6139515-7 | Myelofibrosis
Patient was taking Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: myelofibrosis on Mar 23, 2009 from NORWAY Additional patient health information: Female patient , 25 years of age, was diagnosed with systemic lupus erythematosus and. Plaquenil dosage: . Patient was hospitalized.

6120375-5 | Product Quality Issue, Rash
Adverse event was reported on Mar 13, 2009 by a Female patient taking Plaquenil (View Usage) (Dosage: 200 Mg 1 Tab Bid #60) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 134.0 lb, Patient experienced the following unwanted or unexpected effects: product quality issue, rash (What is rash?).

6102914-3 | Insomnia, Pityriasis Rosea
on Mar 03, 2009 Female patient from UNITED STATES , 65 years of age, weighting 168.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), systemic lupus erythematosus and was treated with Plaquenil (View Usage). Patient had the following side effects: insomnia, pityriasis rosea. Plaquenil dosage: 1 Tablet Daily.

6097043-1 | Rash
on Feb 26, 2009 Female patient from UNITED STATES , weighting 134.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: rash (What is rash?). Plaquenil dosage: 200 Mg Tab Bid #60.

6083181-6 | Anuria, Dyspnoea, Dysuria, Lethargy, Leukocytosis, Mental Status Changes, Nausea, Oedema, Unresponsive To Stimuli
Patient was taking Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, dyspnoea, dysuria, lethargy, leukocytosis, mental status changes, nausea (What is nausea?), oedema, unresponsive to stimuli on Feb 13, 2009 from UNITED STATES Additional patient health information: Female patient , 42 years of age, . Plaquenil dosage: . Patient was hospitalized.

6067125-9 | Product Quality Issue, Rash Erythematous, Rash Pruritic
Adverse event was reported on Feb 04, 2009 by a Female patient taking Plaquenil (View Usage) (Dosage: 200 Mg Bid Po) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 55 years of age, Patient had the following side effects: product quality issue, rash erythematous, rash pruritic.

6060734-2 | Vision Blurred, Visual Acuity Reduced, Visual Impairment
on Jan 30, 2009 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with systemic lupus erythematosus and was treated with Plaquenil (View Usage). After Plaquenil was administered, patient had the following side effects: vision blurred, visual acuity reduced, visual impairment. Plaquenil dosage: 200 Mg 2 X Day.

5957586-5 | Impaired Driving Ability
on Nov 17, 2008 Female patient from UNITED STATES , weighting 120.0 lb, was treated with Plaquenil (View Usage). Patient experienced the following unwanted or unexpected effects: impaired driving ability. Plaquenil dosage: 400 Mg Once A Day. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ).

5935499-2 | Asthenia, Dysphagia, Dysphonia, Dyspnoea Exertional, Lung Infection, Muscular Weakness, Myopathy, Respiratory Failure
Patient was taking Plaquenil (View Usage). Patient had the following side effects: asthenia, dysphagia, dysphonia, dyspnoea exertional, lung infection, muscular weakness, myopathy, respiratory failure on Oct 17, 2008 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with myositis (What is myositis?) and. Plaquenil dosage: 200 Mg. During the same period patient was treated with EZETIMIBE/SIMVASTATIN (Unk) (View Ezetimibe/simvastatin Review and Ezetimibe/simvastatin Label ), DILTIAZEM HCL (Unk) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), RALOXIFENE HCL (Unk) (View Raloxifene Hcl Review and Raloxifene Hcl Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), PREDNISONE TAB (Unk) (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.